tm logo
NANO-OJAS
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 17 Sep 2021

Last Applicant/ Owned by

6 Devoe Place

Chappaqua

NY

10514

Serial Number

86268581 filed on 01st May 2014

Registration Number

4686043 registered on 10th Feb 2015

in the Principal Register

Correspondent Address

Scott D. Locke

SCOTT D. LOCKE

555 THEODORE FREMD AVE

RYE, NY 10580-1451

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NANO-OJAS

Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, al Read More

Classification Information


Class [005]
Pharmaceutical Products


Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of diabetes; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of hypertension; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical solutions used in dialysis; Pharmaceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and pharmaceutical purposes; Therapeutic pharmaceutical for the treatment of obesity


First Use Date in General

21st May 2014

First Use Date in Commerce

21st May 2014

Mark Details


Serial Number

No 86268581

Mark Type

No Service/Collective Mark

Attorney Docket Number

No NANORX 0002-

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Sep 2021CANCELLED SEC. 8 (6-YR)
10th Feb 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10th Feb 2015REGISTERED-PRINCIPAL REGISTER
03rd Jan 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02th Jan 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
31st Dec 2014STATEMENT OF USE PROCESSING COMPLETE
25th Nov 2014TEAS STATEMENT OF USE RECEIVED
25th Nov 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
25th Nov 2014USE AMENDMENT FILED
30th Sep 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED